Share Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma Transcript

Seeking Alpha · XNCR · October 26, 2026

Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma Transcript

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Seeking Alpha ↗